Related Experiment Video

Updated: Aug 9, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Lack of TP53 and FMS gene mutations in children with myelodysplastic syndrome

Biljana Jekic1, Ivana Novakovic, Ljiljana Lukovic

  • 1Institute of Biology and Human Genetics, School of Medicine, 26 Visegradska Str., 11000 Belgrade, Serbia and Montenegro. biljanaj@verat.net

Cancer Genetics and Cytogenetics
|April 25, 2006
PubMed

Insights

Pediatric myelodysplastic syndromes (MDS) differ from adult forms. Researchers found no FMS or TP53 gene mutations in children with MDS, suggesting distinct molecular pathways in pediatric cases.

Area of Science:

  • Pediatric Hematology
  • Molecular Oncology
  • Genetics

Background:

  • Myelodysplastic syndromes (MDS) are uncommon in pediatric populations.
  • The specific molecular drivers of childhood MDS remain largely unknown.
  • Gene mutations in FMS and TP53 are implicated in adult MDS.

Purpose of the Study:

  • To investigate the presence of FMS and TP53 gene mutations in a cohort of pediatric MDS patients.
  • To compare the molecular mechanisms of MDS in children versus adults.

Main Methods:

  • Analysis of mutations in FMS codon 969 and TP53 exons 5-9.
  • Utilized single-strand conformation polymorphism polymerase chain reaction (PCR) techniques.

Main Results:

  • No mutations were detected in the FMS or TP53 genes within the analyzed pediatric MDS cohort.
  • The findings contrast with known mutation profiles in adult MDS.

Conclusions:

  • The molecular pathogenesis of MDS in children appears to differ significantly from that in adults.
  • FMS and TP53 mutations are unlikely to be major contributors to childhood MDS development.

More Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...